Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|July 14, 2023
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2Akitaka Yamamoto, Hideo Wada, Masaki Tomida, et al.
Experimental Neurology|August 22, 2006
Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsyAkitaka Yamamoto, Clara K Schindler, Brona M Murphy, et al.
Journal of Intensive Care|February 24, 2015
A case of Strongyloides hyperinfection associated with tuberculosisYoshiaki Iwashita, Kei Suzuki, Asami Masui, et al.
The Journal of Clinical Investigation|April 2, 2004
Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsySachiko Shinoda, Clara K Schindler, Robert Meller, et al.
Journal of Clinical Medicine|July 2, 2021
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular CoagulationAkitaka Yamamoto, Hideo Wada, Yuhuko Ichkawa, et al.
The Journal of Emergency Medicine|January 30, 2013
Food poisoning associated with Kudoa septempunctataYoshiaki Iwashita, Yoshito Kamijo, Susumu Nakahashi, et al.
Journal of Clinical Medicine|February 25, 2022
Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019Hideo Wada, Yuhuko Ichikawa, Minoru Ezaki, et al.
Journal of Clinical Medicine|September 10, 2021
Evaluation of Biomarkers of Severity in Patients with COVID-19 InfectionAkitaka Yamamoto, Hideo Wada, Yuhuko Ichikawa, et al.
Thrombosis and Haemostasis|April 2, 2025
Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with ThrombosisHideo Wada, Katsuya Shiraki, Yuhuko Ichikawa, et al.
Pageof 4